New IV drug aims to ease debilitating CRPS pain in major trial
NCT ID NCT07210515
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 28 times
Summary
This phase 3 study tests an intravenous drug called AMBTX-01 (neridronate) for people with Complex Regional Pain Syndrome Type 1, a condition causing severe, long-lasting pain in one limb. About 270 adults will receive either the drug or a placebo to see if it safely reduces pain intensity over 12 weeks. The goal is to ease symptoms, not cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLEX REGIONAL PAIN SYNDROME TYPE I are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ambros Clinical Trial Site
RECRUITINGPhoenix, Arizona, 85032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ambros Clinical Trial Site
RECRUITINGTucson, Arizona, 85710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ambros Clinical Trial Site
RECRUITINGTustin, California, 92780, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ambros Clinical Trial Site
RECRUITINGPembroke Pines, Florida, 33025, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ambros Clinical Trial Site
RECRUITINGNewnan, Georgia, 30265, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ambros Clinical Trial Site
RECRUITINGWinston-Salem, North Carolina, 27103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.